List of Chapters/Sections(Table Of Content)
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Therapeutic Nuclear Medicines Market Size Analysis from 2022 to 2027
1.5.1 Global Therapeutic Nuclear Medicines Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Therapeutic Nuclear Medicines Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Therapeutic Nuclear Medicines Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Therapeutic Nuclear Medicines Industry Impact
Chapter 2 Global Therapeutic Nuclear Medicines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Therapeutic Nuclear Medicines (Volume and Value) by Type
2.1.1 Global Therapeutic Nuclear Medicines Consumption and Market Share by Type (2016-2021)
2.1.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2016-2021)
2.2 Global Therapeutic Nuclear Medicines (Volume and Value) by Application
2.2.1 Global Therapeutic Nuclear Medicines Consumption and Market Share by Application (2016-2021)
2.2.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Application (2016-2021)
2.3 Global Therapeutic Nuclear Medicines (Volume and Value) by Regions
2.3.1 Global Therapeutic Nuclear Medicines Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Therapeutic Nuclear Medicines Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Therapeutic Nuclear Medicines Consumption by Regions (2016-2021)
4.2 North America Therapeutic Nuclear Medicines Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Therapeutic Nuclear Medicines Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Therapeutic Nuclear Medicines Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Therapeutic Nuclear Medicines Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Therapeutic Nuclear Medicines Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Therapeutic Nuclear Medicines Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Therapeutic Nuclear Medicines Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Therapeutic Nuclear Medicines Sales, Consumption, Export, Import (2016-2021)
4.10 South America Therapeutic Nuclear Medicines Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Therapeutic Nuclear Medicines Market Analysis
5.1 North America Therapeutic Nuclear Medicines Consumption and Value Analysis
5.1.1 North America Therapeutic Nuclear Medicines Market Under COVID-19
5.2 North America Therapeutic Nuclear Medicines Consumption Volume by Types
5.3 North America Therapeutic Nuclear Medicines Consumption Structure by Application
5.4 North America Therapeutic Nuclear Medicines Consumption by Top Countries
5.4.1 United States Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
5.4.2 Canada Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
5.4.3 Mexico Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
Chapter 6 East Asia Therapeutic Nuclear Medicines Market Analysis
6.1 East Asia Therapeutic Nuclear Medicines Consumption and Value Analysis
6.1.1 East Asia Therapeutic Nuclear Medicines Market Under COVID-19
6.2 East Asia Therapeutic Nuclear Medicines Consumption Volume by Types
6.3 East Asia Therapeutic Nuclear Medicines Consumption Structure by Application
6.4 East Asia Therapeutic Nuclear Medicines Consumption by Top Countries
6.4.1 China Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
6.4.2 Japan Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
6.4.3 South Korea Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
Chapter 7 Europe Therapeutic Nuclear Medicines Market Analysis
7.1 Europe Therapeutic Nuclear Medicines Consumption and Value Analysis
7.1.1 Europe Therapeutic Nuclear Medicines Market Under COVID-19
7.2 Europe Therapeutic Nuclear Medicines Consumption Volume by Types
7.3 Europe Therapeutic Nuclear Medicines Consumption Structure by Application
7.4 Europe Therapeutic Nuclear Medicines Consumption by Top Countries
7.4.1 Germany Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
7.4.2 UK Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
7.4.3 France Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
7.4.4 Italy Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
7.4.5 Russia Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
7.4.6 Spain Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
7.4.7 Netherlands Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
7.4.8 Switzerland Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
7.4.9 Poland Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
Chapter 8 South Asia Therapeutic Nuclear Medicines Market Analysis
8.1 South Asia Therapeutic Nuclear Medicines Consumption and Value Analysis
8.1.1 South Asia Therapeutic Nuclear Medicines Market Under COVID-19
8.2 South Asia Therapeutic Nuclear Medicines Consumption Volume by Types
8.3 South Asia Therapeutic Nuclear Medicines Consumption Structure by Application
8.4 South Asia Therapeutic Nuclear Medicines Consumption by Top Countries
8.4.1 India Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
8.4.2 Pakistan Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Therapeutic Nuclear Medicines Market Analysis
9.1 Southeast Asia Therapeutic Nuclear Medicines Consumption and Value Analysis
9.1.1 Southeast Asia Therapeutic Nuclear Medicines Market Under COVID-19
9.2 Southeast Asia Therapeutic Nuclear Medicines Consumption Volume by Types
9.3 Southeast Asia Therapeutic Nuclear Medicines Consumption Structure by Application
9.4 Southeast Asia Therapeutic Nuclear Medicines Consumption by Top Countries
9.4.1 Indonesia Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
9.4.2 Thailand Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
9.4.3 Singapore Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
9.4.4 Malaysia Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
9.4.5 Philippines Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
9.4.6 Vietnam Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
9.4.7 Myanmar Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
Chapter 10 Middle East Therapeutic Nuclear Medicines Market Analysis
10.1 Middle East Therapeutic Nuclear Medicines Consumption and Value Analysis
10.1.1 Middle East Therapeutic Nuclear Medicines Market Under COVID-19
10.2 Middle East Therapeutic Nuclear Medicines Consumption Volume by Types
10.3 Middle East Therapeutic Nuclear Medicines Consumption Structure by Application
10.4 Middle East Therapeutic Nuclear Medicines Consumption by Top Countries
10.4.1 Turkey Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
10.4.3 Iran Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
10.4.5 Israel Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
10.4.6 Iraq Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
10.4.7 Qatar Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
10.4.8 Kuwait Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
10.4.9 Oman Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
Chapter 11 Africa Therapeutic Nuclear Medicines Market Analysis
11.1 Africa Therapeutic Nuclear Medicines Consumption and Value Analysis
11.1.1 Africa Therapeutic Nuclear Medicines Market Under COVID-19
11.2 Africa Therapeutic Nuclear Medicines Consumption Volume by Types
11.3 Africa Therapeutic Nuclear Medicines Consumption Structure by Application
11.4 Africa Therapeutic Nuclear Medicines Consumption by Top Countries
11.4.1 Nigeria Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
11.4.2 South Africa Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
11.4.3 Egypt Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
11.4.4 Algeria Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
11.4.5 Morocco Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
Chapter 12 Oceania Therapeutic Nuclear Medicines Market Analysis
12.1 Oceania Therapeutic Nuclear Medicines Consumption and Value Analysis
12.2 Oceania Therapeutic Nuclear Medicines Consumption Volume by Types
12.3 Oceania Therapeutic Nuclear Medicines Consumption Structure by Application
12.4 Oceania Therapeutic Nuclear Medicines Consumption by Top Countries
12.4.1 Australia Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
12.4.2 New Zealand Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
Chapter 13 South America Therapeutic Nuclear Medicines Market Analysis
13.1 South America Therapeutic Nuclear Medicines Consumption and Value Analysis
13.1.1 South America Therapeutic Nuclear Medicines Market Under COVID-19
13.2 South America Therapeutic Nuclear Medicines Consumption Volume by Types
13.3 South America Therapeutic Nuclear Medicines Consumption Structure by Application
13.4 South America Therapeutic Nuclear Medicines Consumption Volume by Major Countries
13.4.1 Brazil Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
13.4.2 Argentina Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
13.4.3 Columbia Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
13.4.4 Chile Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
13.4.5 Venezuela Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
13.4.6 Peru Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
13.4.8 Ecuador Therapeutic Nuclear Medicines Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Therapeutic Nuclear Medicines Business
14.1 Novartis AG
14.1.1 Novartis AG Company Profile
14.1.2 Novartis AG Therapeutic Nuclear Medicines Product Specification
14.1.3 Novartis AG Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Bayer
14.2.1 Bayer Company Profile
14.2.2 Bayer Therapeutic Nuclear Medicines Product Specification
14.2.3 Bayer Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 China Isotope & Radiation
14.3.1 China Isotope & Radiation Company Profile
14.3.2 China Isotope & Radiation Therapeutic Nuclear Medicines Product Specification
14.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Q BioMed
14.4.1 Q BioMed Company Profile
14.4.2 Q BioMed Therapeutic Nuclear Medicines Product Specification
14.4.3 Q BioMed Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Curium Pharmaceuticals
14.5.1 Curium Pharmaceuticals Company Profile
14.5.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Specification
14.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Jubilant DraxImage
14.6.1 Jubilant DraxImage Company Profile
14.6.2 Jubilant DraxImage Therapeutic Nuclear Medicines Product Specification
14.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Dongcheng
14.7.1 Dongcheng Company Profile
14.7.2 Dongcheng Therapeutic Nuclear Medicines Product Specification
14.7.3 Dongcheng Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Lantheus
14.8.1 Lantheus Company Profile
14.8.2 Lantheus Therapeutic Nuclear Medicines Product Specification
14.8.3 Lantheus Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Acrotech Biopharma.
14.9.1 Acrotech Biopharma. Company Profile
14.9.2 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Specification
14.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Progenics Pharmaceuticals
14.10.1 Progenics Pharmaceuticals Company Profile
14.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Specification
14.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 International Isotopes
14.11.1 International Isotopes Company Profile
14.11.2 International Isotopes Therapeutic Nuclear Medicines Product Specification
14.11.3 International Isotopes Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Therapeutic Nuclear Medicines Market Forecast (2022-2027)
15.1 Global Therapeutic Nuclear Medicines Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Therapeutic Nuclear Medicines Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Therapeutic Nuclear Medicines Value and Growth Rate Forecast (2022-2027)
15.2 Global Therapeutic Nuclear Medicines Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Therapeutic Nuclear Medicines Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Therapeutic Nuclear Medicines Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Therapeutic Nuclear Medicines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Therapeutic Nuclear Medicines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Therapeutic Nuclear Medicines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Therapeutic Nuclear Medicines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Therapeutic Nuclear Medicines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Therapeutic Nuclear Medicines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Therapeutic Nuclear Medicines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Therapeutic Nuclear Medicines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Therapeutic Nuclear Medicines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Therapeutic Nuclear Medicines Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Therapeutic Nuclear Medicines Consumption Forecast by Type (2022-2027)
15.3.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2022-2027)
15.3.3 Global Therapeutic Nuclear Medicines Price Forecast by Type (2022-2027)
15.4 Global Therapeutic Nuclear Medicines Consumption Volume Forecast by Application (2022-2027)
15.5 Therapeutic Nuclear Medicines Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
